FDA should not grant exemptions to its proposed standard banning menthol in cigarettes that would continue to allow menthol heated tobacco products or low nicotine cigarettes

FDA’s proposed standard banning menthol in cigarettes is very well-done except for its provision that would allow FDA to exempt heated tobacco products like Philip Morris’ IQOS, BAT’s glo or JTI’s Ploom — which are considered “cigarettes” under the law — or low nicotine cigarettes. (FDA has only authorized sale IQOS so far.) This isContinue reading “FDA should not grant exemptions to its proposed standard banning menthol in cigarettes that would continue to allow menthol heated tobacco products or low nicotine cigarettes”

FDA should prohibit all menthol flavor additives, compounds, constituents, and ingredients in cigarettes, and should not limit the proposed standard to prohibiting menthol as a “characterizing flavor”

My colleagues at UCSF and other universities and I have submitted this comment to the FDA in response to its proposal to prohibit the use of menthol in cigarettes. A PDF of the comment is here. The Regulations.gov tracking number is l6b-ew3y-c1ye. FDA should prohibit all menthol flavor additives, compounds, constituents, and ingredients in cigarettes,Continue reading “FDA should prohibit all menthol flavor additives, compounds, constituents, and ingredients in cigarettes, and should not limit the proposed standard to prohibiting menthol as a “characterizing flavor””

Since FDA has made a mess of Juul, the health community & Congress should force FDA to ban menthol e-cigs now

The day after FDA denied Juul’s application to continue selling its e-cigarettes on June 23, 2022, Juul sued and obtained an emergency Stay from the US Court of Appeals.  On July 5, the FDA announced that it was issuing its own Administrative Stay and allowed Juul to remain on the market while the FDA considersContinue reading “Since FDA has made a mess of Juul, the health community & Congress should force FDA to ban menthol e-cigs now”

As a matter of health equity and social justice, FDA should immediately finalize and implement the proposed standard for menthol in cigarettes to reduce smoking-attributable deaths and health disparities among African Americans

Several colleagues at UCSF and elsewhere and I submitted this comment to the FDA on its proposed rule to end menthol in cigarettes. A PDF is here; the regulations.gov tracking number is l4s-xj6c-9kba. As a matter of health equity and social justice, FDA should immediately finalize and implement the proposed standard for menthol in cigarettesContinue reading “As a matter of health equity and social justice, FDA should immediately finalize and implement the proposed standard for menthol in cigarettes to reduce smoking-attributable deaths and health disparities among African Americans”

White House OKs FDA moving forward on reducing nicotine in cigs; FDA can and should ban menthol ecigs now

On June 21, 2022, the Biden Administration announced that FDA would be moving forward to develop a product standard limiting nicotine in cigarettes and other combusted tobacco products to nonaddictive levels. FDA has been formally considering such a rule for a long time. In 2018, FDA solicited public comment on such a rule. At thatContinue reading “White House OKs FDA moving forward on reducing nicotine in cigs; FDA can and should ban menthol ecigs now”

Support for cigarette menthol ban and cigar flavor ban; need to ban menthol as an ingredient not just as a characterizing flavor and to eliminate exceptions for some tobacco products (Statement at June 13, 2022 FDA Listening Session)

My name is Stanton Glantz.  I am a retired Professor of Medicine at the University of California San Francisco and was the principal investigator of the UCSF Tobacco Center of Regulatory Science. The FDA did an excellent job of summarizing the science on the effects of menthol to build a justification for ending the useContinue reading “Support for cigarette menthol ban and cigar flavor ban; need to ban menthol as an ingredient not just as a characterizing flavor and to eliminate exceptions for some tobacco products (Statement at June 13, 2022 FDA Listening Session)”

Cutting phase-in for cig menthol ban from 1 year to 90 days will prevent 265,000 kids from smoking and 12,000 premature deaths

FDA’s draft rule ending menthol cigarettes proposes giving tobacco companies a year to clear menthol cigarettes off the market. FDA requested public comment on shortening the phase in 90 days. My UCSF and Stanford colleagues and I submitted this public comment (PDF version) supporting a 90 day phase in. We noted that FDA’s own analysisContinue reading “Cutting phase-in for cig menthol ban from 1 year to 90 days will prevent 265,000 kids from smoking and 12,000 premature deaths”

FDA granting the tobacco companies’ request to extend the public comment period its menthol cigarette ban will lead to 58,000 more smokers and 2,700 more deaths

FDA has invited public comment on its well-justified rule to get rid of menthol cigarettes. Even though dealing with menthol cigarettes has been being considered and debated for 13 years, the tobacco companies have told FDA they need more time to prepare their comments and asked that the comment period be extended for 60 days.Continue reading “FDA granting the tobacco companies’ request to extend the public comment period its menthol cigarette ban will lead to 58,000 more smokers and 2,700 more deaths”

FDA’s proposed ban on menthol cigarettes explains why FDA needs to reverse its de facto approvals of menthol e-cigarettes

The FDA’s decisions to act on premarket tobacco product applications (PMTAs) for e-cigarettes has been explicit about two points: (1) it is authorizing tobacco flavors because kids don’t seem to use tobacco flavored e-cigs and (2) it is blocking flavored e-cigs – except menthol – because kids like flavors.  Because they can’t justify allowing mentholContinue reading “FDA’s proposed ban on menthol cigarettes explains why FDA needs to reverse its de facto approvals of menthol e-cigarettes”

FDA authorizes two more RJR tobacco e-cigs and lets menthol remain on the market, ignoring its own conclusion that menthol reinforces nicotine addiction in kids’ developing brains

Today (May 12, 2022) FDA announced that it was authorizing the sale of two additional RJR e-cigarettes, Vuse Vibe (a vape pen) and Vuse Ciro (similar to previously authorized Vuse Solo). FDA didn’t act on RJR’s most popular Vuse product, Vuse Alto, so it continues on the market. Following FDA’s de facto policy, both wereContinue reading “FDA authorizes two more RJR tobacco e-cigs and lets menthol remain on the market, ignoring its own conclusion that menthol reinforces nicotine addiction in kids’ developing brains”